Results 231 to 240 of about 1,531,874 (315)

Robvis Shiny App: A tool for risk of bias assessment. [PDF]

Saudi J Anaesth
Borkar N, Nair A, Meshram S.
europepmc   +1 more source

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug

Arthritis Care &Research, EarlyView.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie, Timothy Beukelman, Nicholas P. McCormick, Jeffrey R. Curtis   +3 more
wiley   +1 more source

The impact of a rapid risk of bias assessment compared to a traditional assessment with QUADAS-2

Haston S, Kenny RP, Meader N, Spiers GF, Tanner L, Sagoo GS, Norman G.   +6 more
europepmc   +1 more source

Assessing risk of bias of cohort studies with large language models. [PDF]

Res Synth Methods
Xia D, Lai H, Zhao W, Huang J, Liu J, Ye Z, Liu J, Sun M, Hou L, Pan B, Ge L.   +10 more
europepmc   +1 more source

Moderators of the Effects of Exercise and Manual Therapy for People With Knee and Hip Osteoarthritis: A Secondary Analysis of a Randomized Clinical Trial

Arthritis Care &Research, EarlyView.
Objective This study aimed to investigate potential moderators influencing the effects of manual therapy and exercise therapy on pain and functional outcomes in individuals with knee and/or hip osteoarthritis, using data from the MOA trial. This is a secondary analysis of data from the MOA trial that compares the clinical effectiveness of manual ...
Daniel Cury Ribeiro, Sarah E. Lamb, J. Haxby Abbott   +2 more
wiley   +1 more source

The Alberta Quality Assessment Tool: Risk of Bias (AQAT:RoB) for the Evaluation of Medical Large Language Model Question-Answer Studies: Development and Pilot Validation. [PDF]

J Med Internet Res
Ye C, Mitchell JR, Baumgart DC, Ma Z, Fung AL, Orellana DG, Chowdhury J, Abass A, Katz S, Jaremko JL, Boulanger P, Barber CEH, Lemermeyer G, Jabbari H, Mou L, Mirzaei M, Githumbi MWB, Tandon P, Goebel R, Clark R, Hung W, Abbasi M, Maleki F, Klarenbach S, Abdalla M.   +24 more
europepmc   +1 more source

Prevalence of Systemic Lupus Erythematosus in Australia, 2010–2022: A Population‐Based Study Using Linked National Administrative Health Data

Arthritis Care &Research, EarlyView.
Objective Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition with widely varying global prevalence estimates. The frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the United States or United Kingdom, at 19 to 39 per 100,000 as opposed ...
Lucinda Roper, Rachel Black, Joanna Tieu, Winnie Chen, Matthew Parker, Catherine Hill, Natasha Nassar, Mandana Nikpour   +7 more
wiley   +1 more source

Scoping review of software implementations of risk-of-bias tools and quantitative bias analysis methods for sample selection bias

Hazewinkel A, Curnow E, Tilling K, Hughes RA.   +3 more
europepmc   +1 more source

Survival Odds to Minimize Risk Heterogeneity Bias in Heart Failure Trials: Application to Dapagliflozin. [PDF]

Circ Heart Fail
Myte R, Mattsson A, Poole M, Little DJ, Nyström P, Henderson A, Claggett BL, Gasparyan SB, Solomon SD, McMurray JJV.   +9 more
europepmc   +1 more source

Development and validation of an oral frailty assessment tool for older adults based on the COSMIN risk of bias checklist: a cross-sectional study. [PDF]

BMC Geriatr
Zeng X, Deng S, Huang S, He J, Yu S, Hu L, Ye X, Liu F.   +7 more
europepmc   +1 more source